ICU Medical, Inc.

ICUI • Medical - Instruments & Supplies

$167.58

▲ +1.29 (+0.78%)

Current price

EarningsLatest report: Jun 30, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$4.20B

Growth

14.5%

Cash Flow

4/5

Trend

Mostly stable

Evidence

Positive revenue growth · 9.9%Positive free cash flow · 3.73Consistent free cash flow · 4/5Manageable debt level · 0.66Healthy liquidity · 2.36

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:51 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$167.58

Change0.78%

Shares Out25.04M

Market Cap$4.20B

Enterprise Value$5.13B

52W Range107.00 - 176.27

Beta0.76

P/E139.48

P/S1.94

P/B1.95

P/FCF23.49

EV/Sales2.38

Price$167.58

Change0.78%

Shares Out25.04M

Market Cap$4.20B

Enterprise Value$5.13B

52W Range107.00 - 176.27

Beta0.76

P/E139.48

P/S1.94

P/B1.95

P/FCF23.49

EV/Sales2.38

EV/EBITDA14.68

EV/FCF28.71

Earnings Yield0.72%

FCF Yield4.26%

Dividend Yield0.00%

Gross Margin36.76%

Oper. Margin4.80%

Profit Margin0.03%

Debt/Eq0.66

Current Ratio2.36

Quick Ratio1.13

Revenue 5Y14.52%

FCF 5Y7.45%

Target$186.40

Target Upside11.23%

Target Median$187.00

Target Range163.00 - 200.00

Volume346.38K

Avg Volume295.14K

EPS Surprise0.19

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

35/100

Financial Strength

Debt, cash, stability

68/100

Growth Potential

Revenue and expansion

57/100

Price Attractiveness

Cheap or expensive today

61/100

Why this score▼

Positive revenue growth · 9.9%Positive free cash flow · 3.73Consistent free cash flow · 4/5Manageable debt level · 0.66Healthy liquidity · 2.36Expensive earnings multiple · 4802.44

Analyst view

Analyst sentiment and price target

ICUI

Analyst sentiment

Based on 12 analyst votes · 2026-09-05

96/100

Bullish

Hold

Bearish

Price Target

2026-08-07

Low

$163.00

Mean

$182.00

Median

$182.00

High

$200.00

Company Overview

IPO: 3/31/1992

Industry: Medical - Instruments & Supplies

P/B i: 1.95

Debt / Equity i: 0.66

Operating Margin: 4.80%

Net Margin: 0.03%

ROE i: -

ROIC: -

Financial Health

Score14 / 20

Debt / Equity: 0.66

Current Ratio: 2.36

Quick Ratio: 1.13

Status: Good

Insider Transactions

Recent executive and insider activity

Woolson Daniel

Transaction: 05/22/2026

SELL

Change

-2,123

Price

$132.21

Filing

05/22/2026

Type

SELL

Sanzone Virginia Ruth

Transaction: 05/14/2026

SELL

Change

-2,447

Price

$124.08

Filing

05/15/2026

Type

SELL

Greenberg David C.

Transaction: 05/13/2026

SELL

Change

-1,254

Price

Not reported

Filing

05/13/2026

Type

SELL

Insider	Type	Change	Price	Transaction	Filing
Woolson Daniel	SELL	-2,123	$132.21	05/22/2026	05/22/2026
Sanzone Virginia Ruth	SELL	-2,447	$124.08	05/14/2026	05/15/2026
Greenberg David C.	SELL	-1,254	Not reported	05/13/2026	05/13/2026
Hoffmeister David F	SELL	-1,254	Not reported	05/13/2026	05/13/2026
Abbey Donald	SELL	-1,254	Not reported	05/13/2026	05/13/2026
FINNEY ELISHA W	SELL	-1,254	Not reported	05/13/2026	05/13/2026
Hernandez Laurie	SELL	-1,254	Not reported	05/13/2026	05/13/2026
KENNEDY KOLLEEN T	SELL	-1,254	Not reported	05/13/2026	05/13/2026
Greenberg David C.	SELL	-2,424	$101.06	05/12/2026	05/13/2026
Greenberg David C.	SELL	-2,424	$122.91	05/12/2026	05/13/2026
Abbey Donald	SELL	-704	Not reported	03/25/2026	03/26/2026
Bonnell Brian Michael	SELL	-11,400	Not reported	03/15/2026	03/16/2026
Bonnell Brian Michael	SELL	-3,248	Not reported	03/15/2026	03/16/2026
Jain Vivek	SELL	-17,100	Not reported	03/15/2026	03/16/2026
Jain Vivek	SELL	-4,872	Not reported	03/15/2026	03/16/2026
Sanzone Virginia Ruth	SELL	-5,700	Not reported	03/15/2026	03/16/2026
Sanzone Virginia Ruth	SELL	-1,624	Not reported	03/15/2026	03/16/2026
Sousa Ben	SELL	-1,300	Not reported	03/15/2026	03/16/2026
Woolson Daniel	SELL	-2,924	Not reported	03/15/2026	03/16/2026
Woolson Daniel	SELL	-1,295	$125.85	03/15/2026	03/16/2026

About the Company

ICU Medical, Inc.

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

Source - link

Peers

ARQT HAE HTFL IRON LIVN PBH PRGO TARS TVTX XRAY

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.

GlobeNewsWire

BlackRock Inc. Takes $550.25 Million Position in ICU Medical, Inc. $ICUI

BlackRock Inc. acquired a new position in shares of ICU Medical, Inc. (NASDAQ: ICUI) during the quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,753,409 shares of the medical instruments supplier's stock, valued at approximately $550,250,000. BlackRock Inc. owned about 15.02% of ICU

Defense World

Emerald Investment Advisers LLC Acquires New Position in ICU Medical, Inc. $ICUI

Emerald Investment Advisers LLC acquired a new stake in ICU Medical, Inc. (NASDAQ: ICUI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,314 shares of the medical instruments supplier's stock, valued at approximately $3,711,000. Emerald Investment Advisers LLC owned about 0.10%

Defense World

California State Teachers Retirement System Grows Position in ICU Medical, Inc. $ICUI

California State Teachers Retirement System grew its stake in shares of ICU Medical, Inc. (NASDAQ: ICUI) by 25.2% during the quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 27,512 shares of the medical instruments supplier's stock after purchasing an additional 5,536 shares during the period.

Defense World

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

Benzinga

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-07	1.78	1.97	0.19
2026-02-19	1.68	1.91	0.23
2025-11-06	1.43	2.03	0.6
2025-08-07	1.44	2.1	0.66
2025-05-08	1.23	1.72	0.49
2025-02-27	1.48	2.11	0.63
2024-11-12	1.25	1.59	0.34
2024-08-07	0.98	1.56	0.58
2024-05-07	0.84	0.96	0.12
2024-02-27	1.18	1.57	0.39
2023-11-06	1.29	1.57	0.28
2023-08-07	1.55	1.88	0.33